title: Relationship between haemoglobin, ristocetin-induced platelet aggregation and platelet surface glycoproteins GPIb and GPIIb/IIIa in haemodialysis patients under therapy with recombinant human erythropoietin.
authors.forename: M
authors.initials: M
authors.lastname: Liani
authors.forename: F
authors.initials: F
authors.lastname: Salvati
authors.forename: E
authors.initials: E
authors.lastname: Tresca
authors.forename: L
authors.initials: L
authors.lastname: Vitacolonna
authors.forename: G C
authors.initials: GC
authors.lastname: Di Paolo
authors.forename: M
authors.initials: M
authors.lastname: Golato
authors.forename: C
authors.initials: C
authors.lastname: Velussi
mesh_terms: D000328:Adult; D000368:Aged; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000502:physiology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000378:metabolism*; D011994:Recombinant Proteins; D006435:Renal Dialysis; D012310:Ristocetin
chemical_list: D006454:Hemoglobins; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011994:Recombinant Proteins; D004921:Erythropoietin; D012310:Ristocetin